Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maternal Serum Progesterone And Placental Heme Oxgenase-1 Expression In Early Onset Idiopathic Fetal Growth Restriction: A Case Control Study

NCT07025031 is registered in ClinicalTrials.gov with National University of Malaysia as lead sponsor.

NCT NCT07025031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07025031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maternal Serum Progesterone And Placental Heme Oxgenase-1 Expression In Early Onset Idiopathic Fetal Growth Restriction: A Case Control Study
Lead sponsor
National University of Malaysia
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2025
Completion date
April 1, 2027
Enrollment
58 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic fetal growth restriction